top of page

Home > Specialists > Infectious Diseases > Dr. Bo Zheng (郑波)

Dr. Shijing Deng - Ophthalmologist - Beijing Tongren Hospital Beijing

Specialty & Clinical Focus:

Infectious disease specialist at Peking University First Hospital in Beijing, with a clinical focus on drug-resistant bacterial infections, complex urinary tract infections, post-surgical infections, SAPHO syndrome, and antimicrobial resistance.

Professional Title & Qualifications:

  • Chief Physician & Professor

  • Doctoral Supervisor

  • M.D. (Doctor of Medicine)

Hospital & Department:

Peking University First Hospital – Department of Infectious Diseases (Tier 3A)

(address: No. 8 Xishiku Street, Xicheng District, Beijing, 100034)

Dr. Bo Zheng (郑波) - Infectious Disease Specialist

Personal Biography

Dr. Bo Zheng is a Chief Physician, Professor, and Doctoral Supervisor in the Department of Infectious Diseases at Peking University First Hospital in Beijing. He graduated from Beijing Medical University with a Bachelor’s degree in 1993 and earned an M.D. in Internal Medicine from the same institution in 1999. From 2003 to 2005, he completed postdoctoral research at Gunma University in Japan. His clinical and research work focuses on the diagnosis and treatment of bacterial infectious diseases and mechanisms of bacterial resistance.

Why Choose Dr. Bo Zheng?

For patients dealing with persistent, complex, or drug-resistant bacterial infections, Dr. Bo Zheng’s background combines senior clinical practice with focused research in antimicrobial resistance. As a Chief Physician and Professor at Peking University First Hospital in Beijing, he works in infectious diseases with attention to challenging bacterial infection scenarios, including severe urinary tract infections, infections after artificial joint replacement, prostatitis, enterococcal infections, and SAPHO syndrome.


His roles in the National Antimicrobial Resistance Investigation Net and his work related to clinical pharmacology and rapid antimicrobial susceptibility testing make his background especially relevant when previous antibiotic pathways have not provided enough clarity. For international patients, a remote specialist-review pathway can help organize medical records, laboratory results, prior antibiotic history, and key questions before considering whether an in-person pathway in Beijing may be worth exploring.

Pre-Travel Case Review & Specialist Liaison

Complex or drug-resistant infections often involve culture reports, antimicrobial susceptibility results, imaging, discharge summaries, and a detailed antibiotic history. Through MedBridgeNZ, international patients can request coordination for a pre-travel specialist-review pathway related to Dr. Bo Zheng’s infectious disease focus where available.


MedBridgeNZ coordinates medical-record preparation, translation support, client-authorized documentation transfer, and appointment request communication with the relevant specialist office. This can help clarify administrative and travel feasibility before a patient considers an in-person pathway in Beijing.

Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.

Secure a Remote Case Review with

Dr. Bo Zheng

Areas of Expertise

  • Drug-resistant bacterial infectious diseases

  • Infections following artificial joint replacement surgery

  • Complex urinary tract infections

  • SAPHO syndrome

  • Prostatitis

  • Urinary tract infections during pregnancy

  • Urinary tract infections in children

  • Enterococcal infections

Verified Client Satisfaction Metrics

⭐⭐⭐⭐⭐ 4.9/5.0 Overall Rating

* Treatment Pathway Satisfaction:

4.7/5.0

* Communication & Professionalism:

5.0/5.0

* High demand: Chosen online for specialist liaison and case reviews by over:

12,800 clients

(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)

Work Experience

  • September 1993 – Present: Resident Physician, Attending Physician, Associate Chief Physician, Chief Physician, and Professor at Peking University First Hospital.

  • October 2003 – September 2005: Postdoctoral Researcher at Gunma University, Japan.

Education & Training

  • Bachelor's degree, Beijing Medical University (1993).

  • Medical Doctorate (M.D.) in Internal Medicine, Beijing Medical University (1999).

  • Postdoctoral research, Gunma University, Japan (October 2003 – September 2005).

Awards & Honors

Academic & Professional Memberships

  • Vice-Chairman of the Academic Committee and Head of the Data Analysis Group, National Antimicrobial Resistance Investigation Net (National Health Commission).

  • Head of the Northern Technology Sub-center, National Antimicrobial Resistance Investigation Net.

  • Member of the Infectious Diseases Branch, Chinese Medical Association.

  • Committee Member of the Infection and Inflammation Group, Chinese Urological Association.

  • Committee Member of the Gynecological Infection Disease Collaborative Group, Chinese Society of Obstetrics and Gynecology.

  • Vice Chairman of the Rational Use of Antibiotics Working Committee, Chinese Hospital Association.

  • Editorial Board Member for various medical journals including Clinical Infectious Diseases (Chinese Edition), Infectious Diseases & Immunity, and the Chinese Journal of Clinical Pharmacology.

Research & Publications

  • Inpatient antibacterial use trends and patterns, China, 2013-2021. Published in the Bulletin of the World Health Organization (2023).

  • The Prevalence and Molecular Epidemiology of Vancomycin-Resistant Enterococcus (VRE) Carriage in Patients Admitted to Intensive Care Units in Beijing, China. Published in the Journal of Microbiology, Immunology and Infection (2023).

  • Rapid antimicrobial susceptibility testing by stimulated Raman scattering metabolic imaging and morphological deformation of bacteria. Published in Analytica Chimica Acta (2021).

Selected Peer-Reviewed Publications

  • Peking University First Hospital Procedure for Culturing Pathogenic Microorganisms for Bone and Joint Infection. Infect Drug Resist. 2024;17:3173-3183. PMID: 39070717. DOI: 10.2147/IDR.S464350.

  • Antimicrobial Susceptibility Trends Among Gram-Negative  Bacilli Causing Bloodstream Infections: Results from the China  Antimicrobial Resistance Surveillance Trial (CARST) Program, 2011–2020. Infect Drug Resist. 2022;15:2325-2337. PMID: 35517902. DOI: 10.2147/IDR.S358788.

  • Differential Urinary Microbiota Composition Between Women With and Without Recurrent Urinary Tract Infection. Front Microbiol. 2022;13:888681. PMID: 35722326. DOI: 10.3389/fmicb.2022.888681.

*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.

Frequently Asked Questions (FAQs)

Is Dr. Zheng’s clinical focus relevant to my specific infection?


Dr. Zheng’s clinical focus includes complex bacterial infectious diseases, antimicrobial resistance, recurrent urinary tract infections, infections after artificial joint replacement, enterococcal infections, prostatitis, and SAPHO syndrome. If previous antibiotic pathways have not provided enough clarity, his background may be relevant for a specialist-review request. MedBridgeNZ can help prepare translated records and coordinate appointment-triage communication where available.


Can I request a remote specialist-review pathway before traveling to China?


Yes. MedBridgeNZ can coordinate medical-record collection, translation support, and client-authorized document transfer to the relevant specialist office at Peking University First Hospital where available. The purpose is to support appointment communication and pre-travel case preparation before a patient decides whether an in-person pathway in Beijing is worth exploring. Any clinical opinion is provided by the licensed specialist or hospital, not MedBridgeNZ.


What happens if an in-person pathway in Beijing appears appropriate?


If the relevant third-party specialist office or hospital indicates that onsite review may be appropriate, MedBridgeNZ can assist with appointment request communication, medical invitation or visa-document coordination support, travel planning, translation coordination, and non-clinical bilingual administrative support for hospital visits where separately arranged. Appointment availability, clinical suitability, and treatment plans remain with the hospital or licensed specialist.


Does MedBridgeNZ provide medical advice or prescribe antibiotics?


No. MedBridgeNZ is a medical concierge and logistics coordination provider, not a clinical practice. Diagnosis, treatment planning, prescriptions, and antibiotic decisions are provided only by Dr. Bo Zheng or licensed medical professionals at Peking University First Hospital. MedBridgeNZ’s role is limited to records preparation, translation coordination, appointment communication, scheduling support, and related logistics.

Flexible Ways to Connect with the Specialist

We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:

  • Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.

  • On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.

  • In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.

How MedBridgeNZ Helps You:

MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. For cases involving experts such as Dr. Bo Zheng, we help with appointment request coordination, medical-record preparation, translation coordination, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis, or treatment, and third-party medical or travel costs remain separate unless expressly stated in writing.

bottom of page